Coronary interventions in Europe 1992
نویسندگان
چکیده
منابع مشابه
Percutaneous coronary interventions in Europe 1992-2003.
AIMS The purpose of this registry is to collect data on trends in interventional cardiology within Europe. Special interest focuses on relative increases and ratios in newer revascularization approaches and its distribution in different regions in Europe. We report the data of the year 2003 and give an overview of the development of coronary interventions since 1992, when the first data collect...
متن کاملSocial Security in Portugal: harmonizing for Europe 1992.
One of the most important aspects of the pending free market of the European Community of 1992 is the free movement of labor among the 12 Member States. Without a fairly even level of social security development, such free movement of workers could produce large social and economic dislocations due to the unevenness of economic development within the Community. Portugal, one of the lesser devel...
متن کاملLower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
The objective of this study was to investigate the epidemiology of melanoma across Europe with regard to Breslow thickness and body-site distribution. Incidence data from Cancer Incidence in 5 Continents and the EUROCARE-melanoma database were used: 28?117 melanoma cases from 20 cancer registries in 12 European countries, diagnosed between 1978 and 1992. Regression analysis and general linear m...
متن کاملCoronary/cardiac Interventions
FEBRUARY 2004 I ENDOVASCULAR TODAY I 31 D uring the last 2 decades, percutaneous endovascular therapies have revolutionized the treatment of coronary artery disease. However, the development and dissemination of percutaneous approaches to heart valve disease have been less rapid. Whereas rheumatic mitral stenosis and congenital aortic stenosis are effectively managed by balloon valvuloplasty in...
متن کاملantiplatelet therapy in hemodialysis patients undergoing percutaneous coronary interventions
conclusions this investigation might contribute to delineate the best treatment options for this high risk population. evidence acquisition we reviewed current evidences on the use of antiplatelet therapy in patients with esrd/hd undergoing pci, focusing on the efficacy and safety of specific agents and their indications for detailed clinical settings. results clinical setting in hd patients is...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 1995
ISSN: 1522-9645,0195-668X
DOI: 10.1093/oxfordjournals.eurheartj.a061026